For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.

Human Embryonic Stem Cell Research

All WCMC investigators who intend to perform research involving human embryonic stem cells must submit notification to the Tri-Institutional ESCRO Committee. This requirement applies to all HESC research, regardless of the funding sources. 

ESCRO Submissions:

New Protocol Submissions: 

Annual Progress Reports: Annual reports are due on the anniversary of ESCRO approval, or the submission deadline for ESCRO submisions, whichever is sooner.  

Annual Progress Reports

Amendment Submissions: Amendments are currently submitted using the Tri-Institutional ESCRO Amendment Form.  Submit all forms to

For more information on Tri-Institutional ESCRO, visit the Human Embryonic Stem Cell Research website.


Aileen Orpilla, CCRC, CCRP

WCM ESCRO Administrator

Alavy Sos

Director, Human Research Protection & Compliance
(646) 962-4061